Stockchase Opinions

Jim Cramer - Mad Money ADMA Biologics ADMA-Q BUY ON WEAKNESS Jan 29, 2025

It does have earnings and is not that much of a spec stock, but it's rich at 40x and lacks a catalyst. Buy when shares come down.

$16.380

Stock price when the opinion was issued

biotechnology
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.